Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference
SAN DIEGO, CA–(Marketwire – September 22, 2010) – Cypress Bioscience, Inc. ( NASDAQ : CYPB ) today announced that Jay D. Kranzler, MD, PhD, its Chairman of the Board and Chief Executive Officer, will present at the UBS Global Life Sciences Conference today, September 22, 2010.
Read more:
Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference
Cypress Bioscience Sends Letter to Ramius
SAN DIEGO, CA–(Marketwire – August 17, 2010) – Cypress Bioscience, Inc. ( NASDAQ : CYPB ) today announced that its Board of Directors has sent a letter to Ramius LLC in response to Ramius’ letter dated August 11, 2010.
See the rest here:
Cypress Bioscience Sends Letter to Ramius
Cypress Bioscience Announces Second Quarter 2010 Financial Results
SAN DIEGO, CA–(Marketwire – August 9, 2010) – Cypress Bioscience, Inc. ( NASDAQ : CYPB ) today announced financial results for the second quarter of 2010. The Company reported total revenue of $9.1 million for the quarter ended June 30, 2010, which includes commercial revenues of $8.1 million and revenues under collaborative agreement of $0.8 million
Read more here:
Cypress Bioscience Announces Second Quarter 2010 Financial Results
Cypress Bioscience Announces Agreement to Discontinue Co-Promotion of Savella(R) With Forest Laboratories
SAN DIEGO, CA–(Marketwire – 08/04/10) – Cypress Bioscience, Inc.
Cypress Bioscience In-Licenses BioLineRx’s Novel Antipsychotic
SAN DIEGO, CA–(Marketwire – 06/20/10) – Cypress Bioscience, Inc. (NASDAQ: CYPB – News ) announced that Cypress has entered into an exclusive North American license for the development and commercialization of BioLineRx’s novel antipsychotic (BL-1020, hereafter, CYP-1020), a potential breakthrough treatment for schizophrenia. Specific terms of the transaction were not disclosed, but the total …
Read more here:
Cypress Bioscience In-Licenses BioLineRx’s Novel Antipsychotic
Cypress Bioscience, Inc. to Present at Citi Investment Research’s 2010 Global Healthcare Conference
SAN DIEGO, CA–(Marketwire – May 25, 2010) – Cypress Bioscience, Inc. ( NASDAQ : CYPB ) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Citi 2010 Global Healthcare Conference on May 27, 2010.
Follow this link:
Cypress Bioscience, Inc. to Present at Citi Investment Research’s 2010 Global Healthcare Conference
Cypress Bioscience Announces 2009 Financial Results (Marketwire)
SAN DIEGO, CA–(Marketwire – March 31, 2010) – Cypress Bioscience, Inc. ( NASDAQ : CYPB ) today announced financial results for the quarter and year ended December 31, 2009.
Read the rest here:
Cypress Bioscience Announces 2009 Financial Results (Marketwire)
Cypress Bioscience, Inc. to Present at Cowen and Company 30th Annual Health Care Conference (Marketwire)
SAN DIEGO, CA–(Marketwire – March 8, 2010) – Cypress Bioscience, Inc. ( NASDAQ : CYPB ) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Cowen and Company 30 th Annual Health Care Conference on March 10, 2010.
See more here:
Cypress Bioscience, Inc. to Present at Cowen and Company 30th Annual Health Care Conference (Marketwire)
Cypress Bioscience Announces Third Quarter 2009 Financial Results (Marketwire)
SAN DIEGO, CA–(Marketwire – November 9, 2009) – Cypress Bioscience, Inc.
Here is the original post:
Cypress Bioscience Announces Third Quarter 2009 Financial Results (Marketwire)
